Urinary kallikrein: A marker of blood pressure sensitivity to salt. We evaluated if a rat strain inbred for low urinary kallikrein excretion differs from normal-kallikrein Wistar rats regarding blood pressure levels in basal conditions and during alterations in sodium balance. Blood pressure was measured in unanesthetized rats on normal sodium intake. Then, blood pressure sensitivity to salt was evaluated over a period of 20 days of high sodium diet (0.84 mmol per g chow). Low-kallikrein rats showed greater systolic blood pressure levels (125 3 vs. 114 2 mm Hg in controls, P < 0.01) at nine weeks of age. Systolic blood pressure was increased after sodium loading in the low-kallikrein group and remained unchanged in controls (150 6 vs. 112 2mm Hg, P < 0.01). This effect was associated with a reduced cumulative urinary excretion of sodium in the lowkallikrein rats. No group difference was found in the clearance of endogenous creatinine in basal conditions. Urinary creatinine excretion decreased during sodium loading, particularly in the low-kallikrein group. The group-difference in urinary kallikrein excretion found in basal condi- In addition, renal kallikrein activity and content were reduced in low-kallikrein rats. The latter group showed a greater ratio of heart weight to body wt both in basal conditions and after sodium loading. The ratio of kidney weight to body wt was reduced after sodium loading.
Urinary kallikrein: A marker of blood pressure sensitivity to salt. We evaluated if a rat strain inbred for low urinary kallikrein excretion differs from normal-kallikrein Wistar rats regarding blood pressure levels in basal conditions and during alterations in sodium balance. Blood pressure was measured in unanesthetized rats on normal sodium intake. Then, blood pressure sensitivity to salt was evaluated over a period of 20 days of high sodium diet (0.84 mmol per g chow). Low-kallikrein rats showed greater systolic blood pressure levels (125 3 vs. 114 2 mm Hg in controls, P < 0.01) at nine weeks of age. Systolic blood pressure was increased after sodium loading in the low-kallikrein group and remained unchanged in controls (150 6 vs. 112 2mm Hg, P < 0.01). This effect was associated with a reduced cumulative urinary excretion of sodium in the lowkallikrein rats. No group difference was found in the clearance of endogenous creatinine in basal conditions. Urinary creatinine excretion decreased during sodium loading, particularly in the low-kallikrein group. The group-difference in urinary kallikrein excretion found in basal conditions (6.85 0.31 vs. 20.74 1.71 nkat/24 hr in controls, P < 0.01) was enhanced by high salt diet (2.96 0.67 vs. 22.07 2.47 nkat/24 hr in controls, P < 0.01). In addition, renal kallikrein activity and content were reduced in low-kallikrein rats. The latter group showed a greater ratio of heart weight to body wt both in basal conditions and after sodium loading. The ratio of kidney weight to body wt was reduced after sodium loading.
These results indicate that a genetically-determined defect in urinary kallikrein excretion is associated with a greater blood pressure sensitivity to salt, possibly due to altered renal sodium handling.
The renal kallikrein-kinin system may be implicated in the pathogenesis of arterial hypertension. Decreased urinary kallikrein excretion is found in essential hypertensive patients and in their normotensive offspring [1] , as well as in different rat models of genetic hypertension. Cosegregation of a sequence variation of the kallikrein gene with high blood pressure phenotype in inbred strains derived from the spontaneously hypertensive rat (SHR) and the normotensive Brown Norway rat confirms that this gene may have the capacity to affect blood pressure [2. Kinins, which are derived from the enzymatic action of kallikrein on kininogen, are able to induce vasodilation, diuresis and natriuresis. It is therefore conceivable that sodium retention and body fluid expansion contribute in the pathogenesis of hypertension in subjects with depressed activity of the renal kallikrein-kinin system, and in fact the latter abnormality has been used as a marker of saltsensitivity in normotensive subjects as well as in essential hypertensive patients [3, 4] . However, in spite of the high genetic Received for publication August 25, 1995 and in revised form November 21, 1995 Accepted for publication November 22, 1995 © 1996 by the International Society of Nephrology control of renal kallikrein expression, common environment plays a significant role in its overall variance [5, 6] . Thus, the extent of genetic determination in the association between salt-sensitivity and low kallikrein phenotype remains unknown. Recently, a strain was developed in our laboratory by breeding rats from a Wistar stock according to their urinary kallikrein phenotype. Selection of a genetically-determined low kallikrein phenotype would help clarify whether the latter is associated with higher basal blood pressure levels and with an enhanced blood pressure sensitivity to salt. The aim of the present study was twofold: (1) to evaluate if the basal blood pressure of the low-kallikrein strain differs from that of normal-kallikrein Wistar rats, and (2) to determine possible differences in the blood pressure sensitivity to a dietary salt excess.
Methods
Experiments were performed in a rat strain originated from an outbred Wistar colony (Morini, Como, Italy). From this population, lines were established by two-way selection for high and low urinary kallikrein excretion. Unfortunately, the high kallikrein line was affected by a high degree of infertility that led to extinction of the strain. No breeding problems were encountered with the low-selection line, which was propagated by sisterbrother mating exclusively. This strain showed an initial decline in kallikrein excretion until the fifth generation (F5). Then, urinary kallikrein remained constant until F20, with a clear-cut difference between genders (lower kallikrein levels in males). For the present study, normal Wistar rats (from Morini) were mated in our laboratory and their offspring were used as controls.
Rats were housed at a constant room temperature (24 1°C) and humidity (60 3%) with a 12-hour light/dark cycle. They had free access to rat chow (sodium, 0.12 mmol/g, Mucedola, Milan, Italy) and tap water. All procedures complied with the standards for the care and use of animals as stated in Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Science, Bethesda, MD, USA). Experiment 1. Kallikrein activity and immunoreactive kallikrein levels in urine and renal homogenates in basal conditions To determine the urinary concentration of kallikrein, creatinine and of N-acetyl-f3-D-glucosaminidase (UNAG), 24-hour urine collections were obtained at eight and nine weeks of age from controls and low-kallikrein rats (N = 11 males, each group), maintained in individual metabolic cages. During the collection periods, rats had free access to water but were deprived of food. At nine weeks, they were anesthetized with ether and blood was taken by direct puncture of the heart to measure plasma creatinine. After transcardial perfusion with 20 mL saline, the heart and both kidneys were removed, cleaned, washed in saline, blotted and weighed. Kidneys were then minced and homogenized in 0.1 mol/liter Tris-HC1 buffer (pH 8.2) with a mechanical homogenizer (Ultra Turrax, Janke & Kunkel KG, Staufen, Germany). Since, much of renal kallikrein is bound to plasma membrane and endoplasmatic reticulum, some kidneys (N =4, each group) were homogenized in 10 ml 0.5% sodium deoxycholic acid (pH 8.5). This mixture was incubated for 30 minutes and then sonicated with a microultrasonic cell disrupter (Sonorex; Bandelin Electronic, Berlin, Germany). Homogenates were centrifuged at 17 ,000 g for 40 minutes. All above procedures were carried out at 4°C. Supernatants were then stored at -40°C until assay.
Experiment 2: Effect of high sodium intake on the systolic blood pressure of low-kallikrein rats
Rats were fed a diet with normal sodium content (0.12 mmol per g chow) until the ninth week of age. At this stage, both the control and the low-kallikrein group (N = 8 males each) were assigned to a high (0.84 mmol per g chow) sodium diet for the following 20 days. Concentration of the other nutrients in the chow was not modified. At the end of this period, rats returned to the initial diet (sodium, 0.12 mmol per g chow) for one additional week. Twenty-four-hour urine collections were obtained before and over the first five days of the high sodium diet. During the collection periods, rats were maintained in individual metabolic cages, which allowed for a high degree of accuracy in the measurement of food and water intake by the inclusion of spill catches. The chow was ground and blended before use. Systolic blood pressure (SBP), heart rate (HR), and body wt (body wt) were measured weekly starting from the seventh until the ninth week of age and then every five days. SBP and HR were measured by the tail-cuff plethysmography method (Recorder 8002, Ugo Basile, Biological Research Apparatus, Comerio, Italy) in unanesthetized rats pre-warmed for 10 minutes at 37°C in a thermostatically controlled heating cabinet. Each pressure value was obtained by averaging eight to ten individual readings. At the end of the experiments, rats were killed with an excess of ether anesthesia, and the heart and both kidneys were removed, cleaned, washed in saline, blotted and weighed.
Analytical procedures Urinary volume (UV) was determined gravimetrically. Sodium (UNa) and potassium (UK) concentration in urine was determined by flame photometry and urinary daily excretion was calculated according to the formulas: UNaV = UNa UV and UKV = UK UV, respectively. Creatinine concentration in plasma (Plr) and urine (Ur) was measured by an automatic analyzer (Hitachi 704). The clearance of endogenous creatinine was calculated according to the formula: Clearancecr = UV Uç/l44O Plr and expressed in tl/min per 100 mg kidney weight. Kallikrein activity in urine and homogenates was measured by an end point amidolytic method [7] at 37°C in 0.1 mol/liter Tris-HC1 buffer (pH 8.2) containing soybean trypsin inhibitor (SBTI, 300 g/m1 Sigma Chemical Company, St. Louis, MO, USA). The latter substance was included in the incubation buffer to inhibit plasma kallikrein and trypsin-like enzymes. The reaction was started by adding substrate (D-Val-Leu-Arg-p-nitroanilide, S2266, Kabi Diagnostica, Stockholm, Sweden) to the final concentration of 1.5 mmol/ liter. The increase in optical density (O.D.), that is proportional to the rate of p-nitroaniline formation, was measured at 405 nm every hour (Perkin-Elmer, Oak Brook, IL, USA). The above procedure ensured that the rate of p-nitroaniline released during the incubation was linear (that is, less than 5% of the substrate was consumed). The reaction was stopped by adding 100 jl of 50% (vol/vol) acetic acid. In contrast with esterolytic assays, the method based on S-2266 substrate has been shown to be specific for glandular kallikrein {8]. As stated above, SBTI was added to the incubation buffer to enhance specificity. In addition, each experimental sample had two controls which consisted of: (1) the same sample incubated with substrate in the presence of 50 U/ml aprotinin (Sigma Chemical Company), a glandular kallikrein inhibitor; and (2) the same sample incubated with substrate in the presence of 30 nmol/liter polyclonal antibodies against human glandular kallikrein. Kallikrein affinity-purified sheep anti-rat glandular kallikrein antibodies [9] were kindly provided by Dr.
Julie Chao, University of South Carolina. The ability of antibodies to inhibit the activity of rat glandular kallikrein was preliminary tested on the synthetic substrate S-2266. Since the O.D. of the controls containing aprotinin did not differ from that of the samples incubated with kallikrein antibodies, for final calculations the former was subtracted from O.D. of the corresponding experimental samples. Therefore, kallikrein activity was measured as amidolytic activity inhibited by aprotinin and kallikrein antibodies, but resistant to SBTI. It was expressed in katals (kat) per mL urine or 100 mg kidney weight (1 kat represents the enzyme activity able to cleave 1 mol p-nitroaniline per second).
Kallikrein levels in urine and homogenates were also determined by a highly sensitive and specific radioimmunoassay for rat glandular kallikrein [10] and expressed as g per ml or ng per 100 mg kidney weight, respectively. We found a significant correlation between immunoreactive kallikrein levels and amidolytic activity values in rat urine (y = 3.08x + 0.29, where y and x represent immunoreactive kallikrein and kallikrein activity, respectively; N = 24, r = 0.977, P < 0.001). To calculate urinary excretion, kallikrein activity or immunoreactive kallikrein levels were multiplied by UV. Urinary concentration of NAG was measured by a colorimetric assay (Shionogi & Co. Ltd., Osaka, Japan) immediately after collecting the sample and expressed in U/ml (1 U represents the enzyme activity that releases 1 mmol 3-cresolsulfonphthalein per mm from the substrate 3-cresolsulfonphthaleinyl-N-acetyl-p-Dglucosaminidase). Protein concentration in renal homogenates was determined by the method of Lowry et al [11] .
Statistical analysis
All data are expressed as mean SEM. Multivariate repeatedmeasures ANOVA was performed to test for interaction between time and grouping factor. Univariate ANOVA then was used to test for differences among groups and over time. Differences within or between groups were determined using paired or unpaired Student's t-test, respectively, with the Bonferroni multiple-comparison adjustment. A probability (P) of 0.05 was used as the criterion of significance. Mathematical and statistical analysis were performed with a STATVIEW II package (Brain Power) on an Apple Macintosh IICX computer. 0.4 pkat/mg protein, P < 0.05 for both comparisons, N = 4 each group).
The clearance of endogenous creatinine, an indirect measure of glomerular filtration rate, was similar in the two groups (33. The ratio of heart weight to body wt was greater in lowkallikrein rats (322 5 vs. 296 5 mg/100 g body wt in controls, P < 0.01), whereas the ratio of kidney weight to body wt was similar (358 4 vs. 331 6 mg/lOU g body wt in controls, NS).
As indicated in Figure 1 , the low-kallikrein group showed greater SBP levels (125 3 vs. 114 2 mm Hg in controls, P < 0.01) at nine weeks of age. SBP increased similarly in the two groups during the first 10 days of salt loading. It then returned to basal levels in the control group, whereas a further increase was observed in the low-kallikrein group (150 6 vs. 112 2 mm Hg in controls at 20 days, P < 0.01). A difference in SBP was still observed five days after the rats had returned to normal sodium diet (129 3 vs. 111 2 mm Hg in controls, P < 0.01).
As shown in Figure 2 , the urinary excretion of kallikrein (expressed as amidolytic activity or immunoreactive enzyme) was significantly decreased in the experimental group compared with controls. The group-difference in amidolytic activity was enhanced after three days of high salt diet, due to a significant decrease of the enzyme activity in urine of low-kallikrein rats, while immunoreactive kallikrein levels were not altered by salt loading in either group. As a consequence, the ratio of amidolytic activity to immunoreactive kallikrein excretion was significantly reduced in low-kallikrein rats and this difference became more evident after high salt.
No group difference was detected in basal body wt ( Fig. 1 ) and daily intake of food and water (18.0 0.9 g and 31.4 2.3 ml vs. 17.6 0.5 g and 28.7 1.3 ml, respectively, in controls, NS). Body weight gain of the low-kallikrein rats fed high sodium diet was greater than that of controls (Fig. 1) , while no significant difference was observed regarding the cumulative intake of food and water. As shown in Table 1 , the two groups did not differ in basal conditions as far as UV, UNaV, and UKV are concerned, whereas urinary creatinine excretion was lower in low-kallikrein rats. UV and UNaV increased in both groups during the first five days of high sodium diet; however, the cumulative UNaV of the lowkallikrein group was 23% less than that controls (28.9 2.7 vs.
37.7 5.2 mmol/100 g body wt, P < 0.01), while the cumulative UV was similar (107 18 vs. 111 16 ml/100 g body wt, NS). As a consequence, sodium balance (expressed as the difference between dietary intake and urinary excretion) was positive in the low-kallikrein group and negative in controls (3 vs. -5 mmol Na/100 g body wt). Urinary creatinine excretion was decreased by sodium loading in both groups, but this effect was more pronounced in the low-kallikrein group (Table 1) . At the end of the experiments, the ratio of heart weight to body wt was significantly greater in low-kallikrein rats (331 7 vs. 275 4 mgIlOO g body wt in controls, P < 0.01), whereas the ratio of kidney weight to body wt was lower (329 5 vs. 370 8 mg/100 g body wt in controls, P < 0.01).
Discussion
Urinary kallikrein excretion has been reported to be decreased in various models of genetic hypertension including the OkamotoKyoto (SHR), New Zealand and Milan hypertensive strains and Dhal salt-sensitive rats [12] [13] [14] . At variance with the models reported above, our rat strain was derived by selective breeding for low urinary kallikrein excretion and not on the basis of high blood pressure levels. This is an important difference since the low-kallikrein phenotype of genetic models of hypertension could be secondary to the increase in blood pressure.
Rat urine contains kallikrein-like enzymes, such as esterase A, able to cleave synthetic substrates used in the past for the determination of kallikrein activity. The amidolytic method employed in the present study is much more specific compared with esterolytic assays. Some modifications of the method of Amundsen et al [7] , such as the inclusion of a blank containing antibodies against glandular kallikrein, were introduced to enhance specificity. This discounts the possibility that the decrease in enzymatic activity found in our inbred strain is due to interference of unrelated enzymes. Validation of the amidolytic method was obtained by measuring kallikrein levels with a radioimmunoassay specific for rat glandular kallikrein. Application of the two methods allowed us to recognize that both kallikrein activity and immunoreactive kallikrein levels are decreased in the urine of the imbred strain at eight as well as nine weeks of age. Renal kallikrein levels were also reduced, while kallikrein activity of renal homogenates was found to be decreased only after solubilization of membrane-bound enzyme by deoxycholic acid. Renal kallikrein is a plasma membrane-bound enzyme, synthesized (as active form and inactive precursor) in the tubular cells of the distal nephron and then released into the urine as well as the interstitial compartment of the kidney. Our results support the hypothesis that both the synthesis and the release of kallikrein could be altered in this strain. In addition, the reduction in urinary kallikrein activity might be attributable to: (1) an excess of inhibitors or (2) a defect in the activation process of the inactive precursor. Relevant to the first possibility is the concept that the activity and function of tissue kallikrein are regulated by endogenous kallikrein-binding proteins or kallikrein inhibitors. One such kallikrein-binding protein, kallistatin, is present in rat kidney and forms a covalent complex with tissue kallikrein thus inhibiting its activity [15] . It would be of interest to determine if kallistatin levels are increased in the kidney and urine of the strain imbred in our laboratory. Kallikrein levels measured by radioimmunoassay reflect total kallikrein, while the amidolytic assay allows to determine the active component. Therefore, the result that the ratio of amidolytic activity to immunoreactive kallikrein levels was reduced in urine of low-kallikrein rats, particularly after sodium loading, suggests that activation processes might be altered in this strain. Values represent mean SEM. High sodium diet was started from day 1. Abbreviations are: UV, urinary volume; UNV, urinary sodium excretion; UkV, urinary potassium excretion; Ur, urinary creatinine excretion. P < 0.05 vs. day 0 b P < 0.05 vs controls
In normosodic conditions, the systolic blood pressure of lowkallikrein rats exceeded by 11 mm Hg that of normal-kallikrein rats, a difference that is consistent with the number observed in rats with early post-natal and life-long blockade of bradykinin B2 receptors by the antagonist Hoe 140 [16] and with the predicted contribution of kallikrein gene on overall blood pressure variability [5] . We found that rats given Hoe 140 early after birth have increased sodium concentration in serum and erythrocytes, thus suggesting that sodium and fluid retention occurred as a consequence of kinin blockade [161. It is relevant to this aspect that dietary sodium restriction nullifies the effect of Hoe 140 on blood pressure.
Environmental factors, such as excessive salt intake, can lead to hypertension in humans and rats with genetical susceptibility [4, [12] [13] [14] . Among various putative genetic markers, low urinary excretion of kallikrein reportedly predicts in which subjects an increase in blood pressure occurs during high sodium diet [4] . In the present study, application of dietary sodium loading induced a significant increase in the blood pressure of normal Wistar rats as well as in low-kallikrein rats. However, this effect was only transient in controls, whereas it persisted and was more pronounced in the strain inbred for the low-kallikrein phenotype. At least 15 days of sodium loading were necessary to unmask blood pressure sensitivity to salt in these rats. One week exposure to 2% NaC1 diet was enough in kininogen-deficient rats [17] , which are able to generate very low levels of renal and urinary kinins. Given the longer life span of humans, it is conceivable that difficulties in the recognition of blood pressure sensitivity to salt is due insufficient duration of sodium loading in some experimental protocols.
The low-kallikrein rats showed a decreased urinary excretion of sodium during salt loading. Similar results were reported in kininogen-deficient Brown Norway Katholiek rats, that genetically lack the ability to generate kinins [17] . The possibility that alterations in renal filtration and/or tubular handling of sodium are present in the low-kallikrein rats is supported by the following changes induced by salt loading: (1) positive Na balance, (2) reduced ratio of UNaV to UKV, (3) decreased excretion of creatinine, and (4) increased body wt. It is noteworthy that the latter effect was not associated to alterations in food intake, though changes in energy requirements might have contributed in determining the difference. Based on the above considerations, it is conceivable that the observed increase in blood pressure is due to sodium retention and total fluid volume expansion. A trophic role of the kallikrein-kinin system in postnatal renal development is suggested by the observation that early, life-long blockade of bradykinin receptors suppresses renal growth and reduces urinary creatinine excretion [16] . Consistent with this possibility is our observation that the functional alterations reported above in the low-kallikrein rats were associated with a lower ratio of kidney weight to body wt. However, the latter result was observed in rats whose kidneys were examined at the end of high sodium diet and it ensued from an increase in body wt rather than a decrease in kidney weight. By contrast, no group-difference was observed in normosodic conditions. A systematic and sequential histological examination should be performed to ascertain if the low-kallikrein phenotype is a marker of altered renal maturation. No apparent alteration in the morphology and number of glomeruli was detected at nine weeks of age (P. Madeddu, unpublished observations). Creatinine clearance, an index of glomerular filtration rate, was not altered in basal conditions in low-kallikrein rats. By contrast, the urinary excretion of NAG, a lysosomal enzyme located in the proximal renal tubules, was enhanced. Urinary NAG is used as an early but unspecific marker of renal damage for monitoring the secondary involvement of the kidney in disorders such diabetes and arterial hypertension. The enzyme activity is increased in these conditions because of decreased lysosome stability or a decreased rate of destruction of the enzyme [18] . It is noteworthy that functional abnormalities of the proximal renal tubules have been reported in the Milan hypertensive strain, whose phenotype includes decreased levels of kallikrein in urine [15] .
The greater ratio of heart weight to body wt observed in the low-kallikrein subgroup may be attributable to the increased hemodynamic load. However, the effect on heart weight appears disproportionate to the modest concurrent increase in blood pressure levels. Similar findings were reported in rats with early blockade of bradykinin receptors [16] .
The alterations found in the low-kallikrein rats may be the consequence of genetic drifting and high incidence of recessive traits occurring after continuous breeding of brother to sister. In Table 1 . Effect of high sodium intake in rats with low kallikrein excretion and in controls Day 4 5 this regard, we emphasize that the aim of the present work was not to determine if the low-kallikrein phenotype cosegregates with higher blood pressure levels. This would require comparison with the opposite high-kallikrein phenotype (that we failed to select, due to a high degree of infertility) and hack-cross segregation tests. Thus, the major conclusions that can be drawn from our results is that inherited low urinary kallikrein phenotype does favor an increased blood pressure sensitivity to salt, possibly related to a renal alteration in sodium handling. While there is much more that needs to be defined of this strain, it could prove to be a useful animal model for the study of the renal kallkreinkinin system in salt-induced hypertension. In preliminary experiments, we found that chronic intravenous infusion of rat kallikrein prevents the blood pressure effects of sodium loading in the low-kallikrein strain (P. Madeddu, unpublished observations).
Direct gene delivery of human tissue kallikrein causes a sustained decrease in the blood pressure of SHRs, an effect that is associated to expression of the enzyme in the heart, kidney and lung [19] . Testing kallikrein gene therapy in the low-kallikrein strain would provide additional informations regarding the potential of this new approach for treating salt-sensitive hypertension.
